[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1988

Utility of Subcutaneous Fat Aspiration for the Diagnosis of Systemic Amyloidosis (Immunoglobulin Light Chain)

Author Affiliations

From the Division of Hematology and Internal Medicine, Dysproteinemia Clinic (Drs Gertz and Kyle), and the Department of Laboratory Medicine (Dr Li), Mayo Clinic and Mayo Foundation, Rochester, Minn, and the Department of Rheumatology, Boston University School of Medicine (Dr Shirahama).

Arch Intern Med. 1988;148(4):929-933. doi:10.1001/archinte.1988.00380040169024
Abstract

• To our knowledge, this is the first blind and controlled analysis of subcutaneous fat aspiration for the diagnosis of primary systemic amyloidosis. The procedure was performed on 82 patients with biopsy-proved systemic amyloidosis and 72 normal adult volunteers. Slides from 71 of the 72 controls were read as negative. Slides from 59 (72%) of the 82 patients with amyloidosis were read as positive or weakly positive after staining with alkaline Congo red. Subcutaneous fat aspiration was as sensitive as rectal biopsy and substantially more sensitive than bone marrow biopsy in diagnosing amyloidosis. In six instances fat aspiration would have obviated the need for a more invasive diagnostic biopsy. Subcutaneous fat aspiration is sensitive (72%) and specific (99%) for amyloidosis. It is technically simpler and less expensive than rectal biopsy and permits immediate assessment of specimen adequacy. The concordance rate for two independent pathologists was 95%. Equivocally positive stains should be interpreted with caution because weak nonspecific staining may be seen.

(Arch Intern Med 1988;148:929-933)

×